The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy
Official Title: A Phase I, Randomised, Double-blind, Three-arm, Parallel Group, Multicentre Study to Compare the Pharmacokinetics (PK), Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, European Union [EU] Sourced Keytruda, and the United States of America [US] Sourced Keytruda) in Subjects With Stage II-IIIA Non-small Cell Lung Cancer Following Complete Resection and Adjuvant Platinum-based Chemotherapy
Study ID: NCT06268613
Brief Summary: The goal of this clinical trial is to compare the amount of study drug in patients' blood to confirm that SB27 works in the same way as EU and US sourced Keytruda in early or locally advanced non-small cell lung cancer (NSCLC) patients who underwent surgery and adjuvant chemotherapy. The main question it aims to answer is: • What the body does to the study drug, which is called "pharmacokinetic" Participants will receive investigational product (IP) administration every 3 weeks, maximum 18 cycles over about 51 weeks and blood sample will be collected. Researchers will compare 3 medicines (SB27, EU sourced Keytruda, and US sourced Keytruda) to see if SB27 works in the same way as EU and US sourced Keytruda.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
SB Investigative Site, Busan, , Korea, Republic of
SB Investigative Site, Daegu, , Korea, Republic of
SB Investigative Site, Hwasun, , Korea, Republic of
SB Investigative Site, Jinju, , Korea, Republic of
SB Investigative Site, Seongnam, , Korea, Republic of
SB Investigative Site, Seoul, , Korea, Republic of
SB Investigative Site, Suwon, , Korea, Republic of
SB Investigative Site, Szczecin, , Poland
SB Investigative Site, Leganés, Madrid, Spain
SB Investigative Site, A Coruña, Santiago De Compostela, Spain
SB Investigative Site, Jaén, , Spain
SB Investigative Site, Málaga, , Spain
SB Investigative Site, Adana, , Turkey
SB Investigative Site, Ankara, , Turkey
SB Investigative Site, Istanbul, , Turkey